BDX - Why Is Medical Device Giant Becton Dickinson Stock Trading Lower Today? | Benzinga
Becton, Dickinson, and Company (NYSE: BDX) posted Q4 adjusted EPS of $3.42, slightly missing the consensus of $3.43.
BD reported sales of $5.09 billion, up 6.8% Y/Y (+5.9 on constant currency), slightly beating the consensus of $5.02 billion.
Q4 revenue from base business (which excludes COVID-only diagnostic testing) grew 7.3% as reported, 6.3% currency-neutral ...